{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:25:52Z","timestamp":1792686352230,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jlr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.jlr.2022.100318","type":"journal-article","created":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T11:36:32Z","timestamp":1670412992000},"page":"100318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Six-Transmembrane Epithelial Antigen of Prostate 3 Promotes Hepatic Insulin Resistance and Steatosis"],"prefix":"10.1016","volume":"64","author":[{"given":"Ting","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7256-4871","authenticated-orcid":false,"given":"Wenchang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bizhen","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jlr.2022.100318_bib1","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jhep.2021.10.025","article-title":"The global NAFLD policy review and preparedness index: are countries ready to address this silent public health challenge?","volume":"76","author":"Lazarus","year":"2022","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.jlr.2022.100318_bib2","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global Perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jlr.2022.100318_bib3","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev-pathol-012615-044224","article-title":"Nonalcoholic Fatty Liver Disease: pathogenesis and Disease spectrum","volume":"11","author":"Hardy","year":"2016","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.jlr.2022.100318_bib4","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jhep.2021.09.007","article-title":"NAFLD-driven HCC: safety and efficacy of current and emerging treatment options","volume":"76","author":"Foerster","year":"2022","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.jlr.2022.100318_bib5","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.tem.2019.08.006","article-title":"Emerging molecular targets for treatment of nonalcoholic fatty liver disease","volume":"30","author":"Chen","year":"2019","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.jlr.2022.100318_bib6","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jhep.2022.04.002","article-title":"Breakthroughs in therapies for NASH and remaining challenges","volume":"76","author":"Ratziu","year":"2022","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.jlr.2022.100318_bib7","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/MCG.0000000000000116","article-title":"World Gastroenterology Organisation Global Guidelines: nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"48","author":"Review","year":"2014","journal-title":"J.\u00a0Clin. Gastroenterol."},{"key":"10.1016\/j.jlr.2022.100318_bib8","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1001\/jamainternmed.2016.3202","article-title":"Effects of moderate and vigorous exercise on nonalcoholic fatty liver disease: a randomized clinical trial","volume":"176","author":"Zhang","year":"2016","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.jlr.2022.100318_bib9","article-title":"Regulatory roles of six-transmembrane epithelial antigen of the prostate family members in the occurrence and development of malignant tumors","volume":"9","author":"Chen","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jlr.2022.100318_bib10","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1158\/1541-7786.MCR-11-0281","article-title":"STEAP proteins: from structure to applications in cancer therapy","volume":"10","author":"Gomes","year":"2012","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.jlr.2022.100318_bib11","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.3324\/haematol.2012.063974","article-title":"Metalloreductase Steap3 coordinates the regulation of iron homeostasis and inflammatory responses","volume":"97","author":"Zhang","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.jlr.2022.100318_bib12","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1073\/pnas.0530298100","article-title":"The p53-inducible TSAP6 gene product regulates apoptosis and the cell cycle and interacts with Nix and the Myt1 kinase","volume":"100","author":"Passer","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jlr.2022.100318_bib13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ajh.23920","article-title":"Abnormal erythroid maturation leads to microcytic anemia in the TSAP6\/Steap3 null mouse model","volume":"90","author":"Blanc","year":"2015","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.jlr.2022.100318_bib14","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1038\/cdd.2008.104","article-title":"Exosome secretion, including the DNA damage-induced p53-dependent secretory pathway, is severely compromised in TSAP6\/Steap3-null mice","volume":"15","author":"Lespagnol","year":"2008","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jlr.2022.100318_bib15","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/hep.30882","article-title":"Six-transmembrane epithelial antigen of the prostate 3 deficiency in hepatocytes protects the liver against ischemia-reperfusion injury by suppressing transforming growth factor-\u03b2-activated kinase 1","volume":"71","author":"Guo","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jlr.2022.100318_bib16","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/hep.31242","article-title":"Hepatic regulator of G protein signaling 5 ameliorates nonalcoholic fatty liver disease by suppressing transforming growth factor beta-activated kinase 1-c-Jun-N-terminal kinase\/p38 signaling","volume":"73","author":"Wang","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jlr.2022.100318_bib17","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/s41395-018-0088-6","article-title":"NASH leading cause of liver transplant in women: updated analysis of indications for liver transplant and ethnic and gender variances","volume":"113","author":"Noureddin","year":"2018","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jlr.2022.100318_bib18","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jhep.2017.09.021","article-title":"Hypertension, diabetes, atherosclerosis and NASH: cause or consequence?","volume":"68","author":"Lonardo","year":"2018","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.jlr.2022.100318_bib19","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1053\/j.gastro.2017.01.003","article-title":"Changes in the prevalence of Hepatitis C virus infection, nonalcoholic steatohepatitis, and alcoholic liver disease among patients with cirrhosis or liver failure on the waitlist for liver transplantation","volume":"152","author":"Goldberg","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jlr.2022.100318_bib20","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrgastro.2013.183","article-title":"NAFLD, NASH and liver cancer","volume":"10","author":"Michelotti","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jlr.2022.100318_bib21","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nrd.2017.60","article-title":"Liver disease: conscious uncoupling in NASH","volume":"16","author":"Villanueva","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jlr.2022.100318_bib22","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00125-016-3902-y","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"59","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.jlr.2022.100318_bib23","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.jhep.2011.08.025","article-title":"The interaction of hepatic lipid and glucose metabolism in liver diseases","volume":"56","author":"Bechmann","year":"2012","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.jlr.2022.100318_bib24","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1210\/er.2019-00034","article-title":"The liver as an endocrine organ-linking NAFLD and insulin resistance","volume":"40","author":"Watt","year":"2019","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jlr.2022.100318_bib25","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S1043-2760(00)00323-4","article-title":"Free fatty acids and pathogenesis of type 2 diabetes mellitus","volume":"11","author":"Bergman","year":"2000","journal-title":"Trends Endocrin. Met."},{"key":"10.1016\/j.jlr.2022.100318_bib26","doi-asserted-by":"crossref","first-page":"15080","DOI":"10.1038\/nrdp.2015.80","article-title":"Nonalcoholic fatty liver disease","volume":"1","author":"Brunt","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jlr.2022.100318_bib27","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/hep.30429","article-title":"Modulation of Insulin Resistance in Nonalcoholic Fatty Liver Disease","volume":"70","author":"Khan","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jlr.2022.100318_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201600889","article-title":"Long-term dietary supplementation with low-dose nobiletin ameliorates hepatic steatosis, insulin resistance, and inflammation without altering fat mass in diet-induced obesity","volume":"61","author":"Kim","year":"2017","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.jlr.2022.100318_bib29","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.jhep.2016.02.002","article-title":"Targeting hepatic TRAF1-ASK1 signaling to improve inflammation, insulin resistance, and hepatic steatosis","volume":"64","author":"Xiang","year":"2016","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.jlr.2022.100318_bib30","doi-asserted-by":"crossref","first-page":"10592","DOI":"10.1038\/ncomms10592","article-title":"Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling","volume":"7","author":"Wang","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jlr.2022.100318_bib31","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/hep.28971","article-title":"The E3 Ligase Tripartite Motif 8 Targets TAK1 to Promote Insulin Resistance and Steatohepatitis","volume":"65","author":"Yan","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jlr.2022.100318_bib32","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1210\/jc.2008-0206","article-title":"Expression of six transmembrane protein of prostate 2 in human adipose tissue associates with adiposity and insulin resistance","volume":"93","author":"Arner","year":"2008","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jlr.2022.100318_bib33","first-page":"361","article-title":"STEAP4, a gene associated with insulin sensitivity, is regulated by several adipokines in human adipocytes","volume":"25","author":"Chen","year":"2010","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.jlr.2022.100318_bib34","first-page":"803","article-title":"Monoclonal antibody to the six-transmembrane epithelial antigen of prostate 4 promotes apoptosis and inhibits proliferation and glucose uptake in human adipocytes","volume":"26","author":"Qin","year":"2010","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.jlr.2022.100318_bib35","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nm.4453","article-title":"The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis","volume":"24","author":"Zhang","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.jlr.2022.100318_bib36","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev-physiol-021909-135846","article-title":"Macrophages, inflammation, and insulin resistance","volume":"72","author":"Olefsky","year":"2010","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.jlr.2022.100318_bib37","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cmet.2017.08.002","article-title":"Nonalcoholic fatty liver disease as a nexus of metabolic and Hepatic diseases","volume":"27","author":"Samuel","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.jlr.2022.100318_bib38","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.cmet.2020.03.007","article-title":"TNFAIP3 Interacting Protein 3 Overexpression Suppresses Nonalcoholic Steatohepatitis by Blocking TAK1 Activation","volume":"31","author":"Liu","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.jlr.2022.100318_bib39","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.cmet.2021.05.019","article-title":"Tripartite motif 16 ameliorates nonalcoholic steatohepatitis by promoting the degradation of phospho-TAK1","volume":"33","author":"Wang","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.jlr.2022.100318_bib40","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1172\/JCI74068","article-title":"TAK1-mediated autophagy and fatty acid oxidation prevent hepatosteatosis and tumorigenesis","volume":"124","author":"Inokuchi-Shimizu","year":"2014","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jlr.2022.100318_bib41","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1002\/hep.30075","article-title":"Caspase recruitment domain protein 6 protects against hepatic steatosis and insulin resistance by suppressing apoptosis signal-regulating kinase 1","volume":"68","author":"Sun","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jlr.2022.100318_bib42","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.ajpath.2015.12.028","article-title":"Hepatic Oncostatin M Receptor beta Regulates Obesity-Induced Steatosis and Insulin Resistance","volume":"186","author":"Luo","year":"2016","journal-title":"Am. J. Pathol."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227522001511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227522001511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T18:31:49Z","timestamp":1758306709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227522001511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0022227522001511"],"URL":"https:\/\/doi.org\/10.1016\/j.jlr.2022.100318","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Six-Transmembrane Epithelial Antigen of Prostate 3 Promotes Hepatic Insulin Resistance and Steatosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jlr.2022.100318","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 THE AUTHORS. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"100318"}}